ProteoGenix
ProteoGenix is a privately-held contract research organization specializing in custom antibody discovery, engineering, and production services for biopharma, diagnostics, research, and animal health clients worldwide, leveraging proprietary AI design and high-performance expression platforms.
- Company typePrivate
- Founded2003
- HeadquartersCosta Mesa, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What ProteoGenix does
ProteoGenix is a privately-held contract research organization (CRO) founded in 2003 and headquartered in Schiltigheim, France, with a US subsidiary (ProteoGenix Inc.) in Morrisville, North Carolina. The company specializes in custom antibody discovery, engineering, and production, serving pharmaceutical and biotechnology companies, contract manufacturing organizations (CMOs/CDMOs), academic and cancer research institutions, diagnostics developers, and animal health companies worldwide. Its customer base spans Singapore (National Cancer Centre), the UK (Birmingham University), the United States (Brown University), Spain (Telum Therapeutics), and Israel (Canopy Immuno-Therapeutics), with 70+ antibodies produced through its services currently advancing through clinical trials.
The company operates a platform-plus-services model built around proprietary wet-lab and AI capabilities. Core technology platforms include AIxplore® (AI-driven antibody design for humanization, affinity maturation, and developability optimization), XtenCHO™ Race (CHO transient expression system producing multi-gram protein in 8 days), RocketAbs™ (immunization platform up to 50% faster than competitors), and a 368-donor naïve human antibody library complemented by LibAb-SFDog™, the first naïve dog antibody library on the market. Service offerings span the full antibody value chain: gene synthesis, peptide synthesis, custom antibody production (phage display, hybridoma, single B cell screening), antibody engineering (bispecifics, ADCs, humanization), recombinant protein production across five expression systems (E. coli, B. subtilis, yeast, insect, mammalian), stable cell line development, and epitope mapping. The company also maintains a 30,000+ SKU bioreagent catalog sold via e-commerce.
ProteoGenix operates a dual go-to-market motion: PhD-level account managers handle enterprise custom-service projects (48-hour quotes, 2-24 hour callbacks, multi-year contracts, no-win-no-fee guarantees on certain services, royalty-free IP), while a self-service e-commerce storefront serves the long tail of catalog customers with instant ordering, loyalty programs, and first-order discounts. The company employs approximately 160 collaborators globally (around 40% with PhDs) and holds ISO 9001, ISO 14001, and French CIR R&D tax credit (2023-2027) certifications. The company is founder-controlled with no disclosed institutional investors.
ProteoGenix firmographics
Firmographics- Name
- ProteoGenix
- Legal name
- ProteoGenix SAS
- Website
- https://proteogenix.science
- Company type
- Private
- Founded year
- 2003
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- ProteoGenix is a privately-held contract research organization specializing in custom antibody discovery, engineering, and production services for biopharma, diagnostics, research, and animal health clients worldwide, leveraging proprietary AI design and high-performance expression platforms.
- Ownership category
- akta.pro rank
ProteoGenix industry classification
Industry- Product category
- Antibody Discovery & Biologics Contract Research Services
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417), In-Vitro Diagnostic Substance Manufacturing (325413)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL)
- akta.pro secondary industries
- Bioanalytical & Biomarker CROs (PK/PD/Immunogenicity) (HLAGAAAD), Protein Engineering & Directed Evolution Platforms (enzyme/therapeutic protein optimization) (HLAAAIAC)
Keywords
Where ProteoGenix is headquartered
LocationHeadquarters
- HQ city
- Costa Mesa
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
ProteoGenix business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain, Infrastructure
Revenue model
- Custom Antibody Production Services: Comprehensive antibody development services including discovery, engineering, humanization, and characterization. Revenue generated through project-based fees with no win/no fee guarantees for certain services. Includes hybridoma technology, phage display, and single B cell screening.
- Recombinant Protein Production: Protein expression across multiple systems (E. coli, B. subtilis, yeast, insect cells, mammalian cells) with scalable production from mg to kg-scale. High-throughput screening services available.
- Peptide Synthesis: Custom peptide synthesis from 1 to thousand peptides, ranging from mg to gram-scale. Starting at €1.66/AA in EU or $2.12/AA in US markets.
- Gene Synthesis: Custom gene synthesis with 100% sequence guarantee, starting from €0.14€/bp or $0.18/bp.
- Bioreagents Products: Off-the-shelf products including 6,000+ primary antibodies, 6,000+ recombinant proteins, ELISA assay kits, and cell separation media. 30,000+ total catalog products with 25% first-order discount available.
- Custom Cell Line Development: Stable cell line development services for gram to kg-scale protein production. Services include royalty-free licensing upon full payment for custom deliverables.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Peptide synthesis starting at €1.66/AA |
| Unit Pricing | Pay-as-you-go | Gene synthesis starting at €0.14€/bp |
| Other | Multi-year contract | Custom antibody discovery - 1 month delivery |
| Other | Multi-year contract | Antibody optimization - AI-powered |
| Hybrid | Monthly | Loyalty Program - Points-based rewards |
| Freemium | Pay-as-you-go | First order discount |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels8 records
ProteoGenix product offering
Product offeringCore offering
ProteoGenix is a contract research organization (CRO) that provides end-to-end custom antibody discovery, engineering, and production services, complemented by recombinant protein expression, peptide synthesis, gene synthesis, and stable cell line development. The company combines proprietary wet-lab platforms (phage display, hybridoma, CHO expression) with its AIxplore® AI-driven antibody design platform to deliver integrated antibody solutions from gene to biotherapeutics. It also distributes a catalog of 30,000+ bioreagents (primary antibodies, recombinant proteins, ELISA kits, cell separation media) through its own e-commerce shop.
Product overview
ProteoGenix is a science-driven CRO (Contract Research Organization) specializing in integrated antibody solutions from gene to biotherapeutics and diagnostics. The company operates a platform-plus-services model combining proprietary technologies with comprehensive service offerings. The core technology stack includes AIxplore® (AI-powered antibody design), XtenCHO™ Race (high-performance mammalian expression system), RocketAbs™ (accelerated immunization platform), and proprietary antibody libraries including LibAb-SF-Dog™ (first dog antibody library). Services span the entire development pipeline: custom antibody production (phage display, hybridoma, recombinant), antibody engineering (humanization, bispecifics, ADCs), protein expression (5 expression systems), peptide synthesis, gene synthesis, and cell line development. The company also maintains a catalog of 30,000+ bioreagents including primary antibodies, recombinant proteins, and ELISA kits available through its online shop. Founded in 2003, ProteoGenix serves pharmaceutical, biotech, CMO/CDMO clients across therapeutics, diagnostics, and animal health sectors.
Differentiator
Problem solved
Functional benefit
Products and services
- Custom Antibody Production Services
- Antibody Discovery Services
- Antibody Engineering Services
- Recombinant Antibody Production Services
- VHH Production
- Animal Health Antibodies
- Epitope Mapping Services
- High-Throughput Antibody Production
- Custom Protein Expression Services
- Custom Cell Line Development
- Custom Peptide Synthesis
- Custom Gene Synthesis
- Primary Antibodies (Catalog)
- Recombinant Proteins (Catalog)
- ELISA Assay Kits
- Nycodenz AG®
- AIxplore® AI Antibody Design Service
- XtenCHO™ Race Expression System (incl. Starter Kit)
Quantifiable outcome
- High-affinity antibodies delivered in 1 month with 10⁻⁹ to 10⁻¹² M binding affinity
- +5 more outcomes
Companies that use ProteoGenix
Customer profileNamed customers5 records
Segments4 records
Ideal customer profiles4 records
ProteoGenix technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability5 records
Feature6 records
ProteoGenix partnerships and signals
Strategic signalScale indicators8 records
Recent moves6 records
Expansion highlights6 records
ProteoGenix competitors and assessment
Company assessmentDirect peers
- Synbio Technologies: Gene synthesis, peptide synthesis, and protein expression CRO serving life sciences research. Directly comparable to ProteoGenix's gene synthesis, peptide synthesis, and custom protein expression services.
- Eurogentec (Kaneka): Belgian CRO/CDMO (now part of Kaneka) offering custom antibody production, oligonucleotide synthesis, and peptide services. Highly comparable in therapeutic antibody production and European CRO positioning.
- Rockland Immunochemicals: US-based antibody manufacturer offering custom polyclonal and monoclonal antibody production, conjugation, and assay development. Similar size and service mix to ProteoGenix's catalog and custom antibody businesses.
- Medix Biochemica: Finnish antibody company specializing in monoclonal antibody development and IVD-grade reagent manufacturing. Directly comparable in diagnostic and research antibody production.
- GenScript: Global CRO offering custom antibody services, gene synthesis, peptide synthesis, and protein production — a direct head-to-head competitor across nearly every ProteoGenix service line, with significantly larger scale.
- Sino Biological: Recombinant protein and antibody CRO/CDMO serving research and therapeutic customers with catalog and custom offerings. Directly comparable in antibody discovery, recombinant production, and diagnostic reagent business.
- Absolute Antibody: UK-based recombinant antibody CRO offering custom antibody engineering, production, and sequencing services. Closely comparable in scale and therapeutic antibody focus.
Broad incumbents
- Charles River Laboratories: Global CRO providing antibody discovery and production services as part of its broader preclinical and manufacturing portfolio. Competes with ProteoGenix in therapeutic antibody services but serves a much wider customer base.
- Abcam: Major antibody reagents supplier (now part of Danaher) with a vast catalog of validated antibodies for research and diagnostics. Overlaps with ProteoGenix's catalog bioreagent and custom diagnostic antibody offerings.
- Bio-Techne (R&D Systems): Large life sciences tools company with extensive antibody catalog (R&D Systems), protein reagents, and ELISA kits. Competes with ProteoGenix's catalog bioreagent business and offers custom services through its ProteinSimple and ExoDx brands.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
ProteoGenix social profiles
Digital presenceProteoGenix compliance and trust
Trust signalCompliance2 records
ProteoGenix financial estimates
Financial estimateRevenue estimate
Valuation estimate
ProteoGenix leadership team
Management profileNumber of profiles
Profiles5 records
ProteoGenix subsidiaries and ownership
Company hierarchySubsidiaries1 record
ProteoGenix funding detail
Funding detailFunding overview
Funding rounds6 records
Investors4 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ProteoGenix M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ProteoGenix
What does ProteoGenix do?
ProteoGenix is a contract research organization (CRO) that provides end-to-end custom antibody discovery, engineering, and production services, complemented by recombinant protein expression, peptide synthesis, gene synthesis, and stable cell line development. The company combines proprietary wet-lab platforms (phage display, hybridoma, CHO expression) with its AIxplore® AI-driven antibody design platform to deliver integrated antibody solutions from gene to biotherapeutics. It also distributes a catalog of 30,000+ bioreagents (primary antibodies, recombinant proteins, ELISA kits, cell separation media) through its own e-commerce shop.
Is ProteoGenix a public or private company?
ProteoGenix is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was ProteoGenix founded?
ProteoGenix was founded in 2003. It employs 11 to 50 people.
Where is ProteoGenix based?
ProteoGenix is headquartered in Costa Mesa, United States, in the North America region.
How does ProteoGenix make money?
Six revenue lines are on record. Custom Antibody Production Services are the primary driver. The others are recombinant Protein Production, peptide Synthesis, gene Synthesis, bioreagents Products and custom Cell Line Development.
Who are ProteoGenix's main competitors?
Direct peers on record are Synbio Technologies, Eurogentec (Kaneka), Rockland Immunochemicals, Medix Biochemica, GenScript, Sino Biological and Absolute Antibody. Broad incumbents are Charles River Laboratories, Abcam and Bio-Techne (R&D Systems).
Does ProteoGenix have an API?
No public API is recorded for ProteoGenix.
What industry is ProteoGenix in?
ProteoGenix's product category is Antibody Discovery & Biologics Contract Research Services. Its primary akta.pro industry code is HLAGAAAL, Specialty Therapeutic-Area CROs (e.g., oncology/rare disease), with a secondary code of HLAGAAAD, Bioanalytical & Biomarker CROs (PK/PD/Immunogenicity). Its NAICS code is 541714 and its SIC code is 2835.